DEVELOPMENT OF NEPHROPROTECTANT: Polyaspartic acid - in vitro studies

Lysoderivative release

(% of base line)

0

20

40

60

80

100

GM

CT

PAA

GM

+

PAA

Kishore et al [1990] J. Pharmacol Exp Ther 255:867-874

Previous slide

Next slide

Back to first slide

View graphic version